Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

NCT00198380

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +10 more
Locations: CHU Besancon - Pneumologie Besançon, France

APHP - CHU Avicenne - Oncologie Medicale Bobigny, France

Centre F. Baclesse Caen, France

CHU - Pneumologie Caen, France

View Trial Details

Completed

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

NCT06298123

Conditions: Adenocarcinoma, Adjuvant Immunotherapy, Carcinoma, +11 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Completed

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

NCT04627012

Conditions: Adenocarcinoma, Anti-PD1 Antibody, Carcinoma, +10 more
Locations: Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

NCT02620280

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations: Brustgesundheitzentrum Tirol, Univ. Frauenklinik Innsbruck Innsbruck, Austria

Universitätsklinik für Innere Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum Salzburg, Austria

Klinikum Augsburg International Patient Service Augsburg, Germany

Frauenarzt-Zentrum-Zehlendorf Berlin, Germany

View all 41 locations

View Trial Details

Completed

Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma

NCT04310943

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Zhou Chengzhi Guangzhou, Guangdong, China

View Trial Details

Completed

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

NCT04618367

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

NCT02527304

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +33 more
Locations: Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT01466036

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

NCT02592356

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant

NCT02182687

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Lahey Hospital & Medical Center Burlington, Massachusetts, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions